Gene therapy injection for hard-to-treat eye pressure disease

This trial is testing a new gene therapy called GVB-2001, delivered as a single injection directly into the front of your eye. The study wants to see if this treatment can safely lower eye pressure in people with primary open-angle glaucoma (a type of glaucoma where pressure inside the eye is too high). Researchers will enroll a small group of patients to carefully monitor how safe the treatment is and how well it works.

Primary open-angle glaucoma can lead to blindness if eye pressure stays too high, and some patients don't get enough relief from eye drops or other current treatments. This trial is exploring whether this new medication approach could offer a different way to control eye pressure and potentially prevent vision loss.